Eight versus four induction cycles of Carfilzomib, Thalidomide and Low-dose Dexamethasone: the Carthadex trial

被引：0

作者：

Wester, Ruth ^{[1
]}

Zweegman, Sonja ^{[2
]}

Van der Holt, Bronno ^{[3
]}

Jose, Kersten Marie ^{[4
]}

Vellenga, Edo ^{[5
]}

van Marwijk-Kooy, Marinus ^{[6
]}

Asselbergs, Emelie ^{[1
]}

de Weerdt, Okke ^{[7
]}

Minnema, Monique ^{[8
]}

Lonergan, Sarah ^{[9
]}

Palumbo, Antonio ^{[10
]}

Broijl, Annemiek ^{[1
]}

Sonneveld, Pieter ^{[1
]}

机构：

[1] Erasmus MC, Canc Inst, Rotterdam, Netherlands

[2] Vrije Univ Amsterdam, Amsterdam UMC, Amsterdam, Netherlands

[3] HOVON Data Ctr, Rotterdam, Netherlands

[4] Univ Amsterdam, Med Ctr, Amsterdam, Netherlands

[5] Univ Med Ctr Groningen, Groningen, Netherlands

[6] Isala Clin, Zwolle, Netherlands

[7] St Antonius Hosp, Nieuwegein, Netherlands

[8] Univ Med Ctr Utrecht, Utrecht, Netherlands

[9] European Myeloma Network, Rotterdam, Netherlands

[10] Univ Turin, Azienda Osped Univ Citta Salute & Sci Torino, Turin, Italy

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2019年 / 19卷 / 10期

关键词：

survival; Tolerability; treatment;

D O I：

10.1016/j.clml.2019.09.367

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

SP-041

引用

页码：E220 / E221

页数：2

共 50 条

[41] Low-dose versus high-dose cyclosporine induction protocols in renal transplantation
Ghafari, A.
Makhdoomi, K.
Ahmadpour, P.
Afshari, A. T.
Fallah, M. M.
Rad, P. S.
TRANSPLANTATION PROCEEDINGS, 2007, 39 (04) : 1219 - 1222
[42] Once-weekly carfilzomib, pomalidomide, and low-dose dexamethasone for relapsed/refractory myeloma: a phase I/II study
Bringhen, Sara
Mina, Roberto
Cafro, Anna Maria
Liberati, Anna Marina
Spada, Stefano
Belotti, Angelo
Gaidano, Gianluca
Patriarca, Francesca
Troia, Rossella
Fanin, Renato
De Paoli, Lorenzo
Rossi, Giuseppe
Lombardo, Alessandra
Bertazzoni, Paola
Palumbo, Antonio
Sonneveld, Pieter
Boccadoro, Mario
LEUKEMIA, 2018, 32 (08) : 1803 - 1807
[43] Once-weekly carfilzomib, pomalidomide, and low-dose dexamethasone for relapsed/refractory myeloma: a phase I/II study
Sara Bringhen
Roberto Mina
Anna Maria Cafro
Anna Marina Liberati
Stefano Spada
Angelo Belotti
Gianluca Gaidano
Francesca Patriarca
Rossella Troia
Renato Fanin
Lorenzo De Paoli
Giuseppe Rossi
Alessandra Lombardo
Paola Bertazzoni
Antonio Palumbo
Pieter Sonneveld
Mario Boccadoro
Leukemia, 2018, 32 : 1803 - 1807
[44] LABOR INDUCTION WITH CONTINUOUS LOW-DOSE OXYTOCIN INFUSION - A RANDOMIZED TRIAL
MERCER, B
PILGRIM, P
SIBAI, B
OBSTETRICS AND GYNECOLOGY, 1991, 77 (05): : 659 - 663
[45] HIGH-DOSE VERSUS LOW-DOSE DEXAMETHASONE IN EXPERIMENTAL EPIDURAL SPINAL-CORD COMPRESSION
DELATTRE, JY
ARBIT, E
ROSENBLUM, MK
THALER, HT
LAU, N
GALICICH, JH
POSNER, JB
NEUROSURGERY, 1988, 22 (06) : 1005 - 1007
[46] Low-dose thalidomide ameliorates cytopenias and splenomegaly in myelofibrosis with myeloid metaplasia: A phase II trial
Marchetti, M
Barosi, G
Balestri, F
Viarengo, G
Gentili, S
Barulli, S
Demory, JL
Ilariucci, F
Volpe, A
Bordessoule, D
Grossi, A
Le Bousse-Kerdiles, MC
Caenazzo, A
Pecci, A
Falcone, A
Broccia, G
Bendotti, C
Bauduer, F
Buccisano, F
Dupriez, B
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (03) : 424 - 431
[47] A phase 2 trial of combination low-dose thalidomide and prednisone for the treatment of myelofibrosis with myeloid metaplasia
Mesa, RA
Steensma, DP
Pardanani, A
Li, CY
Elliott, M
Kaufmann, SH
Wiseman, G
Gray, LA
Schroeder, GE
Reeder, T
Zeldis, JB
Tefferi, A
BLOOD, 2003, 101 (07) : 2534 - 2541
[48] Bortezomib, Lenalidomide and Low-Dose Dexamethasone (VRD) Versus Lenalidomide and Low-Dose Dexamethasone (Ld) for Newly-Diagnosed Multiple Myeloma- a Randomized Phase III Study
Mookerjee, Anjali
Gupta, Ritu
Jasrotia, Shivali
Sahoo, Ranjit
Kumar, Rakesh
Thulkar, Sanjay
Sharma, Om Dutt
Kumar, Lalit
BLOOD, 2017, 130
[49] Carfilzomib and dexamethasone versus eight cycles of bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma: an indirect comparison using data from the phase 3 ENDEAVOR and CASTOR trials
Weisel, Katja
Majer, Istvan
DeCosta, Lucy
Oriol, Albert
Goldschmidt, Hartmut
Ludwig, Heinz
Campioni, Marco
Szabo, Zsolt
Dimopoulos, Meletios
LEUKEMIA & LYMPHOMA, 2020, 61 (01) : 37 - 46
[50] Low-dose thalidomide plus monthly high-dose oral dexamethasone (Thali-Dexa): Results, prognostic factors and side effects in eight patients previously treated with multiple myeloma
Bernardeschi, P
Dentico, P
Rossi, S
Fiorentini, G
Giustarini, G
Turano, E
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2003, 22 (04) : 129 - 133

← 1 2 3 4 5 →